Establishing an <it>in vivo </it>model of canine prostate carcinoma using the new cell line CT1258

<p>Abstract</p> <p>Background</p> <p>Prostate cancer is a frequent finding in man. In dogs, malignant disease of the prostate is also of clinical relevance, although it is a less common diagnosis. Even though there are numerous differences in origin and development of t...

Full description

Bibliographic Details
Main Authors: Winkler Susanne, Willenbrock Saskia, Sterenczak Katharina A, Soller Jan T, Escobar Hugo, Fork Melani AM, Dorsch Martina, Reimann-Berg Nicola, Hedrich Hans J, Bullerdiek Jörn, Nolte Ingo
Format: Article
Language:English
Published: BMC 2008-08-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/8/240
_version_ 1818444658374606848
author Winkler Susanne
Willenbrock Saskia
Sterenczak Katharina A
Soller Jan T
Escobar Hugo
Fork Melani AM
Dorsch Martina
Reimann-Berg Nicola
Hedrich Hans J
Bullerdiek Jörn
Nolte Ingo
author_facet Winkler Susanne
Willenbrock Saskia
Sterenczak Katharina A
Soller Jan T
Escobar Hugo
Fork Melani AM
Dorsch Martina
Reimann-Berg Nicola
Hedrich Hans J
Bullerdiek Jörn
Nolte Ingo
author_sort Winkler Susanne
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Prostate cancer is a frequent finding in man. In dogs, malignant disease of the prostate is also of clinical relevance, although it is a less common diagnosis. Even though there are numerous differences in origin and development of the disease, man and dog share many similarities in the pathological presentation. For this reason, the dog might be a useful animal model for prostate malignancies in man.</p> <p>Although prostate cancer is of great importance in veterinary medicine as well as in comparative medicine, there are only few cell lines available. Thus, it was the aim of the present study to determine whether the formerly established prostate carcinoma cell line CT1258 is a suitable tool for <it>in vivo </it>testing, and to distinguish the growth pattern of the induced tumours.</p> <p>Methods</p> <p>For characterisation of the <it>in vivo </it>behaviour of the <it>in vitro </it>established canine prostate carcinoma cell line CT1258, cells were inoculated in 19 NOD.CB17-<it>Prkdc</it><sup><it>Scid</it></sup>/J (in the following: NOD-Scid) mice, either subcutaneously or intraperitoneally. After sacrifice, the obtained specimens were examined histologically and compared to the pattern of the original tumour in the donor.</p> <p>Cytogenetic investigation was performed.</p> <p>Results</p> <p>The cell line CT 1258 not only showed to be highly tumourigenic after subcutaneous as well as intraperitoneal inoculation, but also mimicked the behaviour of the original tumour.</p> <p>Conclusion</p> <p>Tumours induced by inoculation of the cell line CT1258 resemble the situation in naturally occurring prostate carcinoma in the dog, and thus could be used as <it>in vivo </it>model for future studies.</p>
first_indexed 2024-12-14T19:19:26Z
format Article
id doaj.art-78b0157bdc544c51b79f29717d871baa
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-14T19:19:26Z
publishDate 2008-08-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-78b0157bdc544c51b79f29717d871baa2022-12-21T22:50:23ZengBMCBMC Cancer1471-24072008-08-018124010.1186/1471-2407-8-240Establishing an <it>in vivo </it>model of canine prostate carcinoma using the new cell line CT1258Winkler SusanneWillenbrock SaskiaSterenczak Katharina ASoller Jan TEscobar HugoFork Melani AMDorsch MartinaReimann-Berg NicolaHedrich Hans JBullerdiek JörnNolte Ingo<p>Abstract</p> <p>Background</p> <p>Prostate cancer is a frequent finding in man. In dogs, malignant disease of the prostate is also of clinical relevance, although it is a less common diagnosis. Even though there are numerous differences in origin and development of the disease, man and dog share many similarities in the pathological presentation. For this reason, the dog might be a useful animal model for prostate malignancies in man.</p> <p>Although prostate cancer is of great importance in veterinary medicine as well as in comparative medicine, there are only few cell lines available. Thus, it was the aim of the present study to determine whether the formerly established prostate carcinoma cell line CT1258 is a suitable tool for <it>in vivo </it>testing, and to distinguish the growth pattern of the induced tumours.</p> <p>Methods</p> <p>For characterisation of the <it>in vivo </it>behaviour of the <it>in vitro </it>established canine prostate carcinoma cell line CT1258, cells were inoculated in 19 NOD.CB17-<it>Prkdc</it><sup><it>Scid</it></sup>/J (in the following: NOD-Scid) mice, either subcutaneously or intraperitoneally. After sacrifice, the obtained specimens were examined histologically and compared to the pattern of the original tumour in the donor.</p> <p>Cytogenetic investigation was performed.</p> <p>Results</p> <p>The cell line CT 1258 not only showed to be highly tumourigenic after subcutaneous as well as intraperitoneal inoculation, but also mimicked the behaviour of the original tumour.</p> <p>Conclusion</p> <p>Tumours induced by inoculation of the cell line CT1258 resemble the situation in naturally occurring prostate carcinoma in the dog, and thus could be used as <it>in vivo </it>model for future studies.</p>http://www.biomedcentral.com/1471-2407/8/240
spellingShingle Winkler Susanne
Willenbrock Saskia
Sterenczak Katharina A
Soller Jan T
Escobar Hugo
Fork Melani AM
Dorsch Martina
Reimann-Berg Nicola
Hedrich Hans J
Bullerdiek Jörn
Nolte Ingo
Establishing an <it>in vivo </it>model of canine prostate carcinoma using the new cell line CT1258
BMC Cancer
title Establishing an <it>in vivo </it>model of canine prostate carcinoma using the new cell line CT1258
title_full Establishing an <it>in vivo </it>model of canine prostate carcinoma using the new cell line CT1258
title_fullStr Establishing an <it>in vivo </it>model of canine prostate carcinoma using the new cell line CT1258
title_full_unstemmed Establishing an <it>in vivo </it>model of canine prostate carcinoma using the new cell line CT1258
title_short Establishing an <it>in vivo </it>model of canine prostate carcinoma using the new cell line CT1258
title_sort establishing an it in vivo it model of canine prostate carcinoma using the new cell line ct1258
url http://www.biomedcentral.com/1471-2407/8/240
work_keys_str_mv AT winklersusanne establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258
AT willenbrocksaskia establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258
AT sterenczakkatharinaa establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258
AT sollerjant establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258
AT escobarhugo establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258
AT forkmelaniam establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258
AT dorschmartina establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258
AT reimannbergnicola establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258
AT hedrichhansj establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258
AT bullerdiekjorn establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258
AT nolteingo establishinganitinvivoitmodelofcanineprostatecarcinomausingthenewcelllinect1258